CN Patent
CN105848661A — 用于预防或治疗铁缺乏的包含铁氧化物纳米颗粒的药物组合物
Assigned to Hanwha Chemical Corp · Expires 2016-08-10 · 10y expired
What this patent protects
本发明涉及一种用于预防或治疗铁缺乏和与此伴随的缺铁性贫血的药物组合物以及该药物组合物的制备方法,所述药物组合物包含铁氧化物纳米颗粒。
USPTO Abstract
本发明涉及一种用于预防或治疗铁缺乏和与此伴随的缺铁性贫血的药物组合物以及该药物组合物的制备方法,所述药物组合物包含铁氧化物纳米颗粒。
Drugs covered by this patent
- Monoferric (FERRIC DERISOMALTOSE) · Pharmacosmos
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.